» Articles » PMID: 14659909

A Sensitive Method for Detecting Proliferation of Rare Autoantigen-specific Human T Cells

Overview
Publisher Elsevier
Date 2003 Dec 9
PMID 14659909
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to measure proliferation of rare antigen-specific T cells among many bystanders is critical for the evaluation of cellular immune function in health and disease. T-cell proliferation in response to antigen has been measured almost exclusively by 3H-thymidine incorporation. This method does not directly identify the phenotype of the proliferating cells and is frequently not sufficiently sensitive to detect rare autoantigen-specific T cells. To overcome these problems, we developed a novel assay for antigen-specific human T-cell proliferation. Peripheral blood mononuclear cells (PBMC) were labelled with the fluorescent dye 5,6-carboxylfluorescein diacetate succinimidyl ester (CFSE) and cells that proliferated in response to antigen, with resultant reduction in CFSE intensity, were measured directly by flow cytometry. This assay was more sensitive than 3H-thymidine incorporation and detected the proliferation of rare antigen-specific CD4(+) T cells at 10-fold lower antigen concentrations. It also allowed the phenotype of the proliferating cells to be directly determined. Using the CFSE assay we were able to measure directly the proliferation of human CD4(+) T cells from healthy donors in response to the type 1 diabetes autoantigens glutamic acid decarboxylase (GAD) and proinsulin (PI).

Citing Articles

Soluble CD52 mediates immune suppression by human seminal fluid.

Harrison L, Stone N, Bandala-Sanchez E, Huntington N, McLachlan R, Rautela J Front Immunol. 2024; 15:1497889.

PMID: 39737172 PMC: 11682959. DOI: 10.3389/fimmu.2024.1497889.


Proinsulin C-peptide is a major source of HLA-DQ8 restricted hybrid insulin peptides recognized by human islet-infiltrating CD4 T cells.

Bhattacharjee P, Pakusch M, Lacorcia M, Tresoldi E, Rubin A, Foster A PNAS Nexus. 2024; 3(11):pgae491.

PMID: 39554513 PMC: 11565411. DOI: 10.1093/pnasnexus/pgae491.


A minority of proliferating human CD4 T cells in antigen-driven proliferation assays are antigen specific.

Bhattacharjee P, Pakusch M, Lacorcia M, Chiu C, Liu X, Tresoldi E Front Immunol. 2024; 15:1491616.

PMID: 39530093 PMC: 11550966. DOI: 10.3389/fimmu.2024.1491616.


MDSCs use a complex molecular network to suppress T-cell immunity in a pulmonary model of fungal infection.

Kaminski V, Borges B, Santos B, Preite N, Calich V, Loures F Front Cell Infect Microbiol. 2024; 14:1392744.

PMID: 39035356 PMC: 11257977. DOI: 10.3389/fcimb.2024.1392744.


Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays.

Walsh R, Nix A, Ackaert C, Mazy A, Schockaert J, Pattyn S Front Immunol. 2024; 15:1406040.

PMID: 38863708 PMC: 11165089. DOI: 10.3389/fimmu.2024.1406040.